These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2575605)

  • 1. Synthesis and in vivo characterization of D-(+)-(N1-[11C]methyl)-2-Br-LSD: a radioligand for positron emission tomographic studies of serotonin 5-HT2 receptors.
    Lever JR; Dannals RF; Wilson AA; Ravert HT; Scheffel U; Hoffman BJ; Hartig PR; Wong DF; Wagner HN
    Int J Rad Appl Instrum B; 1989; 16(7):697-704. PubMed ID: 2575605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of serotonin 5-HT2 receptors in living human brain by positron emission tomography using N1-([11C]-methyl)-2-Br-LSD.
    Wong DF; Lever JR; Hartig PR; Dannals RF; Villemagne V; Hoffman BJ; Wilson AA; Ravert HT; Links JM; Scheffel U
    Synapse; 1987; 1(5):393-8. PubMed ID: 2905532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodinated D-(+)-N1-ethyl-2-iodolysergic acid diethylamide: a ligand for in vitro and in vivo studies of serotonin receptors.
    Lever JR; Scheffel UA; Musachio JL; Stathis M; Wagner HN
    Life Sci; 1991; 48(15):PL73-8. PubMed ID: 2011045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N1-methyl-2-125I-lysergic acid diethylamide, a preferred ligand for in vitro and in vivo characterization of serotonin receptors.
    Hoffman BJ; Scheffel U; Lever JR; Karpa MD; Hartig PR
    J Neurochem; 1987 Jan; 48(1):115-24. PubMed ID: 3794694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo binding of 125I-LSD to serotonin 5-HT2 receptors in mouse brain.
    Hartig PR; Scheffel U; Frost JJ; Wagner HN
    Life Sci; 1985 Aug; 37(7):657-64. PubMed ID: 3160905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors.
    Scheffel U; Lever JR; Stathis M; Ricaurte GA
    Neuropharmacology; 1992 Sep; 31(9):881-93. PubMed ID: 1359444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biodistribution of a new radiotracer for in vivo labeling of serotonin uptake sites by PET, cis-N,N-[11C]dimethyl-3-(2',4'-dichlorophenyl)-indanamine (cis-[11C]DDPI).
    Suehiro M; Scheffel U; Dannals RF; Wilson AA; Ravert HT; Wagner HN
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):549-53. PubMed ID: 1399685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 123I-MSP and F[11C]MSP: new selective 5-HT2A receptor radiopharmaceuticals for in vivo studies of neuronal 5-HT2 serotonin receptors. Synthesis, in vitro binding study with unlabelled analogues and preliminary in vivo evaluation in mice.
    Samnick S; Remy N; Ametamey S; Bader JB; Brandau W; Kirsch CM
    Life Sci; 1998; 63(22):2001-13. PubMed ID: 9839544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [11C]MDL 100907, a radioligland for selective imaging of 5-HT(2A) receptors with positron emission tomography.
    Lundkvist C; Halldin C; Ginovart N; Nyberg S; Swahn CG; Carr AA; Brunner F; Farde L
    Life Sci; 1996; 58(10):PL 187-92. PubMed ID: 8602111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone.
    Blin J; Sette G; Fiorelli M; Bletry O; Elghozi JL; Crouzel C; Baron JC
    J Neurochem; 1990 May; 54(5):1744-54. PubMed ID: 2182776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo study of central serotoninergic receptors in man using positron tomography].
    Baron JC; Samson Y; Comar D; Crouzel C; Deniker P; Agid Y
    Rev Neurol (Paris); 1985; 141(8-9):537-45. PubMed ID: 2935920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological characterization of a new PET ligand for the serotonin transporter: [11C]5-bromo-2-[2-(dimethylaminomethylphenylsulfanyl)]phenylamine ([11C]DAPA).
    Huang Y; Hwang DR; Zhu Z; Bae SA; Guo N; Sudo Y; Kegeles LS; Laruelle M
    Nucl Med Biol; 2002 Oct; 29(7):741-51. PubMed ID: 12381454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile synthesis of [11C]buprenorphine for positron emission tomographic studies of opioid receptors.
    Lever JR; Mazza SM; Dannals RF; Ravert HT; Wilson AA; Wagner HN
    Int J Rad Appl Instrum A; 1990; 41(8):745-52. PubMed ID: 2172186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N1-methyl-2-[125I]LSD ([125I]MIL), a preferred ligand for serotonin 5-HT2 receptors.
    Hoffman BJ; Karpa MD; Lever JR; Hartig PR
    Eur J Pharmacol; 1985 Mar; 110(1):147-8. PubMed ID: 4007051
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The radiosynthesis of [N-methyl-11C]-sertraline.
    Lasne MC; Pike VW; Turton DR
    Int J Rad Appl Instrum A; 1989; 40(2):147-51. PubMed ID: 2541104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635.
    Hall H; Lundkvist C; Halldin C; Farde L; Pike VW; McCarron JA; Fletcher A; Cliffe IA; Barf T; Wikström H; Sedvall G
    Brain Res; 1997 Jan; 745(1-2):96-108. PubMed ID: 9037397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.